TY - JOUR
T1 - Endoscopic biliary drainage using a 4-Fr catheter for biliary obstruction
T2 - a pilot study
AU - Kuniyoshi, Noriyuki
AU - Imazu, Hiroo
AU - Nomura, Shuzo
AU - Hamana, Suguru
AU - Osawa, Rota
AU - Yamada, Kouji
AU - Fujisawa, Mariko
AU - Moriyama, Mitsuhiko
N1 - Publisher Copyright:
© 2022 Society of Medical Innovation and Technology.
PY - 2022
Y1 - 2022
N2 - Introduction: Stent or endoscopic nasobiliary drainage (ENBD) catheter placement for a tight, complicated biliary stricture is still technically challenging. A thin, 4-Fr ENBD catheter (4-Fr catheter) has been developed to overcome this difficulty. The study aimed to evaluate the feasibility of the 4-Fr catheter for endoscopic biliary drainage (EBD). Material and methods: We performed a retrospective review of 51 patients who underwent EBD with the 4-Fr catheter because placement of a conventional drainage catheter (CDC) had failed. Results: The success rate of 4-Fr catheter placement was 96.1% (49/51). The median patency period of the catheter was 114 days (95% CI, 53–200). Among the 49 patients with successful placement of the catheter, adverse events occurred in five (10.2%) patients: post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), two patients; catheter dislocation, one patient; and kinking of the 4-Fr catheter, two patients. Both cases of PEP improved with conservative treatment, but all cases of catheter dislocation and kinking required reintervention with a 4-Fr catheter. Forty-three (87.8%) patients achieved clinical remission after EBD with a 4-Fr catheter. Conclusions: The newly developed 4-Fr catheter is safe and feasible for EBD in patients in whom CDC placement is difficult due to a tight, complicated biliary stricture.
AB - Introduction: Stent or endoscopic nasobiliary drainage (ENBD) catheter placement for a tight, complicated biliary stricture is still technically challenging. A thin, 4-Fr ENBD catheter (4-Fr catheter) has been developed to overcome this difficulty. The study aimed to evaluate the feasibility of the 4-Fr catheter for endoscopic biliary drainage (EBD). Material and methods: We performed a retrospective review of 51 patients who underwent EBD with the 4-Fr catheter because placement of a conventional drainage catheter (CDC) had failed. Results: The success rate of 4-Fr catheter placement was 96.1% (49/51). The median patency period of the catheter was 114 days (95% CI, 53–200). Among the 49 patients with successful placement of the catheter, adverse events occurred in five (10.2%) patients: post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), two patients; catheter dislocation, one patient; and kinking of the 4-Fr catheter, two patients. Both cases of PEP improved with conservative treatment, but all cases of catheter dislocation and kinking required reintervention with a 4-Fr catheter. Forty-three (87.8%) patients achieved clinical remission after EBD with a 4-Fr catheter. Conclusions: The newly developed 4-Fr catheter is safe and feasible for EBD in patients in whom CDC placement is difficult due to a tight, complicated biliary stricture.
KW - 4-Fr catheter
KW - Endoscopic biliary drainage
KW - endoscopic biliary stenting
KW - endoscopic nasobiliary drainage
KW - tight biliary strictures
UR - http://www.scopus.com/inward/record.url?scp=85132773619&partnerID=8YFLogxK
U2 - 10.1080/13645706.2022.2090004
DO - 10.1080/13645706.2022.2090004
M3 - Article
C2 - 35732006
AN - SCOPUS:85132773619
SN - 1364-5706
VL - 31
SP - 1035
EP - 1040
JO - Minimally Invasive Therapy and Allied Technologies
JF - Minimally Invasive Therapy and Allied Technologies
IS - 7
ER -